## Background: The efficacy of the nonabsorbable antibiotic rifaximin in patients with active acute or chronic pouchitis is unknown. ## Methods: We performed a placebo-controlled pilot trial to evaluate the efficacy and safety of rifaximin in patients with active pouchitis. eighteen patients with
β¦ LIBER β¦
Leukocytapheresis for the treatment of active pouchitis: a pilot study
β Scribed by Yasumi Araki; Keiichi Mitsuyama; Takaaki Nagae; Yuji Tou; Motonori Nakagawa; Yasue Iwatani; Masakazu Harada; Hiroyuki Ozasa; Michio Sata; Toshihiro Noake
- Book ID
- 106180320
- Publisher
- Springer Japan
- Year
- 2008
- Tongue
- English
- Weight
- 430 KB
- Volume
- 43
- Category
- Article
- ISSN
- 0944-1174
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Rifaximin for the treatment of active po
β
Kim L. Isaacs; Robert S. Sandler; Maria Abreu; Michael F. Picco; Stephen B. Hana
π
Article
π
2007
π
John Wiley and Sons
π
English
β 132 KB
π 2 views
Pilot study: the use of sulfasalazine fo
β
A. BELLUZZI; M. SERRANI; G. RODA; M. L. BIANCHI; L. CASTELLANI; M. GRAZIA; G. RO
π
Article
π
2009
π
John Wiley and Sons
π
English
β 68 KB
High-Dose Probiotics for the Treatment o
β
Paolo Gionchetti; Fernando Rizzello; Claudia Morselli; Gilberto Poggioli; Rosi T
π
Article
π
2007
π
Springer
π
English
β 293 KB
High-Dose Probiotics for the Treatment o
β
Paolo Gionchetti; Fernando Rizzello; Claudia Morselli; Gilberto Poggioli; Rosi T
π
Article
π
2007
π
Springer
π
English
β 293 KB
Feasibility of Five Days of Consecutive
β
Tomoyuki Tsujikawa; Akira Andoh; Atsuhiro OgaαΊa; Ayano Sonoda; Yuhki Yagi; Kazuo
π
Article
π
2009
π
John Wiley and Sons
π
English
β 233 KB
A pilot study of pioglitazone treatment
β
Kittichai Promrat; Glen Lutchman; Gabriel I. Uwaifo; Renee J. Freedman; Alejandr
π
Article
π
2004
π
John Wiley and Sons
π
English
β 146 KB
π 2 views
Nonalcoholic steatohepatitis (NASH) is a common chronic liver disease for which there is no known effective therapy. A proportion of patients with NASH progress to advanced fibrosis and cirrhosis. NASH is considered one of the clinical features of the metabolic syndrome in which insulin resistance p